This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Sinai Health System. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Salomé Adam: Innovator in Cancer Treatment
Introduction
Salomé Adam is a prominent inventor based in Toronto, Canada. He has made significant contributions to the field of cancer treatment, particularly in addressing homologous recombination deficient cancers. His innovative work has led to the development of a patent that holds promise for improving cancer therapies.
Latest Patents
Salomé Adam holds a patent for the "Treatment of homologous recombination deficient cancers." This patent discloses compounds, compositions, uses, and methods that utilize inhibitors of the CIP2A-TOPBP1 complex. It also includes agents that inhibit phosphopeptide recognition of TOPBP1 BRCT7/8, aimed at treating cancers associated with or characterized by homologous recombination deficiency.
Career Highlights
Adam is affiliated with Sinai Health System, where he continues to advance his research and innovations in cancer treatment. His work is crucial in developing new therapeutic strategies for patients suffering from specific types of cancer.
Collaborations
Salomé Adam collaborates with notable colleagues, including Daniel Durocher and Silvia Emma Rossi. These partnerships enhance the research efforts and contribute to the advancement of cancer treatment methodologies.
Conclusion
Salomé Adam's contributions to cancer treatment through his innovative patent demonstrate his commitment to improving patient outcomes. His work is a testament to the importance of research and collaboration in the fight against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile